SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001764013-21-000127
Filing Date
2021-11-23
Accepted
2021-11-23 16:27:09
Documents
12
Period of Report
2021-11-17
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K imvt-20211117.htm   iXBRL 8-K 34767
  Complete submission text file 0001764013-21-000127.txt   170499

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20211117.xsd EX-101.SCH 1908
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20211117_lab.xml EX-101.LAB 23970
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20211117_pre.xml EX-101.PRE 12642
5 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20211117_htm.xml XML 10825
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38906 | Film No.: 211438831
SIC: 2836 Biological Products, (No Diagnostic Substances)